Literature DB >> 26430259

Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years.

Christopher J Kemp1.   

Abstract

The identification of carcinogens in the workplace, diet, and environment through chemical carcinogenesis studies in animals has directly contributed to a reduction of cancer burden in the human population. Reduced exposure to these carcinogens through lifestyle changes, government regulation, or change in industry practices has reduced cancer incidence in exposed populations. In addition to providing the first experimental evidence for cancer's relationship to chemical and radiation exposure, animal models of environmentally induced cancer have and will continue to provide important insight into the causes, mechanisms, and conceptual frameworks of cancer. More recently, combining chemical carcinogens with genetically engineered mouse models has emerged as an invaluable approach to study the complex interaction between genotype and environment that contributes to cancer development. In the future, animal models of environmentally induced cancer are likely to provide insight into areas such as the epigenetic basis of cancer, genetic modifiers of cancer susceptibility, the systems biology of cancer, inflammation and cancer, and cancer prevention.
© 2015 Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26430259      PMCID: PMC4949043          DOI: 10.1101/pdb.top069906

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  87 in total

1.  Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.

Authors:  K Brown; A Buchmann; A Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

3.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma.

Authors:  Brian C Lewis; David S Klimstra; Nicholas D Socci; Su Xu; Jason A Koutcher; Harold E Varmus
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 5.  Cancer in rodents: does it tell us about cancer in humans?

Authors:  Vladimir N Anisimov; Svetlana V Ukraintseva; Anatoly I Yashin
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

6.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

7.  Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice.

Authors:  N R Drinkwater; J J Ginsler
Journal:  Carcinogenesis       Date:  1986-10       Impact factor: 4.944

Review 8.  The role of transgenic mouse models in carcinogen identification.

Authors:  John B Pritchard; John E French; Barbara J Davis; Joseph K Haseman
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

9.  The carcinogenesis bioassay in perspective: application in identifying human cancer hazards.

Authors:  V A Fung; J C Barrett; J Huff
Journal:  Environ Health Perspect       Date:  1995 Jul-Aug       Impact factor: 9.031

Review 10.  The need for epidemiological studies of the medical exposures of Japanese patients to the carcinogen ethyl carbamate (urethane) from 1950 to 1975.

Authors:  J A Miller
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  13 in total

Review 1.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

Review 2.  Toxicity testing is evolving!

Authors:  Ida Fischer; Catherine Milton; Heather Wallace
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

Review 3.  Optimizing mouse models for precision cancer prevention.

Authors:  Clémentine Le Magnen; Aditya Dutta; Cory Abate-Shen
Journal:  Nat Rev Cancer       Date:  2016-02-19       Impact factor: 60.716

4.  N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes.

Authors:  Mariam R Habil; Raúl A Salazar-González; Mark A Doll; David W Hein
Journal:  Arch Toxicol       Date:  2022-09-16       Impact factor: 6.168

Review 5.  Preclinical mouse solid tumour models: status quo, challenges and perspectives.

Authors:  Nicolas Gengenbacher; Mahak Singhal; Hellmut G Augustin
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

Review 6.  DNA Damage, Mutagenesis and Cancer.

Authors:  Ashis K Basu
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

7.  Successful development of squamous cell carcinoma and hyperplasia in RGEN-mediated p27 KO mice after the treatment of DMBA and TPA.

Authors:  Jun Young Choi; Woo Bin Yun; Ji Eun Kim; Mi Rim Lee; Jin Ju Park; Bo Ram Song; Hye Ryeong Kim; Ji Won Park; Mi Ju Kang; Byeong Cheol Kang; Han-Woong Lee; Dae Youn Hwang
Journal:  Lab Anim Res       Date:  2018-09-27

Review 8.  Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.

Authors:  Yoshiaki Maru; Kunishige Onuma; Masako Ochiai; Toshio Imai; Yoshitaka Hippo
Journal:  Cancer Sci       Date:  2019-02-03       Impact factor: 6.716

Review 9.  Tumour neoantigen mimicry by microbial species in cancer immunotherapy.

Authors:  Maximilian Boesch; Florent Baty; Sacha I Rothschild; Michael Tamm; Markus Joerger; Martin Früh; Martin H Brutsche
Journal:  Br J Cancer       Date:  2021-04-06       Impact factor: 7.640

Review 10.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Sarah Warren; Sandy Adjemian; Patrizia Agostinis; Aitziber Buqué Martinez; Timothy A Chan; George Coukos; Sandra Demaria; Eric Deutsch; Dobrin Draganov; Richard L Edelson; Silvia C Formenti; Jitka Fucikova; Lucia Gabriele; Udo S Gaipl; Sofia R Gameiro; Abhishek D Garg; Encouse Golden; Jian Han; Kevin J Harrington; Akseli Hemminki; James W Hodge; Dewan Md Sakib Hossain; Tim Illidge; Michael Karin; Howard L Kaufman; Oliver Kepp; Guido Kroemer; Juan Jose Lasarte; Sherene Loi; Michael T Lotze; Gwenola Manic; Taha Merghoub; Alan A Melcher; Karen L Mossman; Felipe Prosper; Øystein Rekdal; Maria Rescigno; Chiara Riganti; Antonella Sistigu; Mark J Smyth; Radek Spisek; John Stagg; Bryan E Strauss; Daolin Tang; Kazuki Tatsuno; Stefaan W van Gool; Peter Vandenabeele; Takahiro Yamazaki; Dmitriy Zamarin; Laurence Zitvogel; Alessandra Cesano; Francesco M Marincola
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.